88 related articles for article (PubMed ID: 8064734)
1. Characterization of chondrocyte alkaline phosphatase as a potential mediator in the dissolution of calcium pyrophosphate dihydrate crystals.
Xu Y; Pritzker KP; Cruz TF
J Rheumatol; 1994 May; 21(5):912-9. PubMed ID: 8064734
[TBL] [Abstract][Full Text] [Related]
2. Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals.
Xu Y; Cruz TF; Pritzker KP
J Rheumatol; 1991 Oct; 18(10):1606-10. PubMed ID: 1765989
[TBL] [Abstract][Full Text] [Related]
3. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals.
Shinozaki T; Xu Y; Cruz TF; Pritzker KP
J Rheumatol; 1995 Jan; 22(1):117-23. PubMed ID: 7699658
[TBL] [Abstract][Full Text] [Related]
4. Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions.
Shinozaki T; Pritzker KP
J Rheumatol; 1996 Apr; 23(4):677-83. PubMed ID: 8730126
[TBL] [Abstract][Full Text] [Related]
5. Polyamines enhance calcium pyrophosphate dihydrate crystal dissolution.
Shinozaki T; Pritzker KP
J Rheumatol; 1995 Oct; 22(10):1907-12. PubMed ID: 8991990
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
7. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist.
Johnson K; Farley D; Hu SI; Terkeltaub R
Arthritis Rheum; 2003 May; 48(5):1302-14. PubMed ID: 12746903
[TBL] [Abstract][Full Text] [Related]
8. CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes.
Nishida T; Kubota S; Nakanishi T; Kuboki T; Yosimichi G; Kondo S; Takigawa M
J Cell Physiol; 2002 Jul; 192(1):55-63. PubMed ID: 12115736
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
[TBL] [Abstract][Full Text] [Related]
10. Interaction between zonal populations of articular chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP.
Jiang J; Leong NL; Mung JC; Hidaka C; Lu HH
Osteoarthritis Cartilage; 2008 Jan; 16(1):70-82. PubMed ID: 17644010
[TBL] [Abstract][Full Text] [Related]
11. Transduction mechanisms of porcine chondrocyte inorganic pyrophosphate elaboration.
Ryan LM; Kurup IV; Cheung HS
Arthritis Rheum; 1999 Mar; 42(3):555-60. PubMed ID: 10088779
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a human articular cartilage-derived chondrocyte cell line that retains chondrocyte phenotype.
Hoffman BE; Newman-Tarr TM; Gibbard A; Wang S; Hanning C; Pratta MA; Boyle RJ; Kumar S; Majumdar MK
J Cell Physiol; 2010 Mar; 222(3):695-702. PubMed ID: 20020445
[TBL] [Abstract][Full Text] [Related]
13. [Hexosaminidase and alkaline phosphatase in cartilage and chondrocyte cultures obtained from normal and arthritic rabbit joints].
Mokondjimobe E; Vignon E; Hecquet C; Bourbouze R; Adolphe M
Pathol Biol (Paris); 1991 Oct; 39(8):759-62. PubMed ID: 1837075
[TBL] [Abstract][Full Text] [Related]
14. Mercaptopyruvate inhibits tissue-nonspecific alkaline phosphatase and calcium pyrophosphate dihydrate crystal dissolution.
Kannampuzha JV; Tupy JH; Pritzker KP
J Rheumatol; 2009 Dec; 36(12):2758-65. PubMed ID: 19884277
[TBL] [Abstract][Full Text] [Related]
15. Chondrocyte viability and metabolic activity after treatment of bovine articular cartilage with bipolar radiofrequency: an in vitro study.
Amiel D; Ball ST; Tasto JP
Arthroscopy; 2004 May; 20(5):503-10. PubMed ID: 15122140
[TBL] [Abstract][Full Text] [Related]
16. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
Pritzker KP; Cheng PT; Renlund RC
J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystals in vitro.
Derfus B; Steinberg M; Mandel N; Buday M; Daft L; Ryan L
J Rheumatol; 1995 Aug; 22(8):1514-9. PubMed ID: 7473476
[TBL] [Abstract][Full Text] [Related]
18. Mechanical regulation of terminal chondrocyte differentiation via RGD-CAP/beta ig-h3 induced by TGF-beta.
Ohno S; Tanaka N; Ueki M; Honda K; Tanimoto K; Yoneno K; Ohno-Nakahara M; Fujimoto K; Kato Y; Tanne K
Connect Tissue Res; 2005; 46(4-5):227-34. PubMed ID: 16546826
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture.
Sailor LZ; Hewick RM; Morris EA
J Orthop Res; 1996 Nov; 14(6):937-45. PubMed ID: 8982137
[TBL] [Abstract][Full Text] [Related]
20. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals.
Xu Y; Cruz T; Cheng PT; Pritzker KP
J Rheumatol; 1991 Jan; 18(1):66-71. PubMed ID: 1850802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
